Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMVAMUNE Booster Vaccination Two Years After Priming
NCT00686582Phase 2Completed
- Sponsor
- Bavarian Nordic
- Start
- Aug 2008
- Primary completion
- Dec 2008
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of JYNNEOS in smallpox, sponsored by Bavarian Nordic. Started Aug 2008; status: completed.
02
Drugs
JYNNEOS
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT00686582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686582.